| Model Number |
C503 |
| Medical Device Problem Code |
Non Reproducible Results (4029)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
12/12/2022
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The investigation is ongoing.
|
| |
|
Event or Problem Description
|
|
There was an allegation of questionable altlp alanine aminotransferase acc.To ifcc with pyridoxal phosphate activation results for 1 patient sample on a cobas pro c 503 analytical unit.On (b)(6) 2022, the first sample's initial altlp result was 272 u/l.The result was reported outside of the laboratory.A 1:2 dilution was made from the sample and the result was 582 u/l.On (b)(6) 2022, a third 1:2 dilution was made from the first sample.The altlp result was 1150 u/l.A 1:5 dilution was made from the first sample and the result was 970 u/l.A 1:10 dilution was made from the first sample and the result was 842 u/l.A second sample was collected.The altp result was 508 u/l.A 1:2 dilution was made using the second sample and the altlp result was 852 u/l.On (b)(6) 2022, the first sample was tested again and the result was 921 u/l.The reagent lot number is 66105201.The expiration date was requested but not provided.
|
| |
|
Additional Manufacturer Narrative
|
|
The alarm trace from (b)(6) 2022 was inconspicuous.No further data was provided for the investigation.A general reagent issue was excluded.The investigation determined the event was consistent with a pre-analytical sample handling issue.The investigation did not identify a product problem.The specific cause of the event could not be determined.
|
| |
|
Additional Manufacturer Narrative
|
|
Sections a2, a3, and b7 have been updated.
|
| |
|
Search Alerts/Recalls
|